Find A PhysicianHome  |  Library  |  myDownstate  |  Newsroom  |  A-Z Guide  |  E-mail  |  Contact Us  |  Directions
curve gif

Incubator Company Profiles

  HealthBeat Brooklyn reports on Downstate's Biotech Initiative and Incubator
 

   

Accutar Biotechnology, Inc.

Accutar's focus is on hybrid method-based drug discovery.

Contact: Jie Fan, Founder & CEO (646-462-5083)

jiefan@accutarbio.com - olafan@gmail.com

www.accutarbio.com


Applied Biological Laboratories Inc.

Applied Biological Laboratories Inc. is a biotechnology company committed to research, development, manufacturing and distribution of scientifically validated natural products.   

http://www.appliedbioinc.com/


AzurRx BioPharma, Inc.


AzurRx BioPharma, Inc. is a biotechnology company that develops non-systemic recombinant protein therapies for the treatment of gastrointestinal (GI) and infectious diseases. AzurRx's two leading therapeutics are: MS1819 Lipase (Phase IIa) for the treatment of severe malnutrition associated with Chronic Pancreatitis and Cystic Fibrosis; and AZX1101 (preclinical) which reduces the incidence of Clostridium difficile infection, one of the most common hospital acquired infections.

Contact: Martin Krusin, Vice President, Business Development (646-699-7855)

info@azurrx.com

www.azurrx.com


BioHealthWays, Inc.

BioHealthWays is changing the business model of how therapeutics are currently delivered into the eye. Our product is a biodegradable sustained release implant to deliver biologics inside the eye. We are addressing the following two markets with our formulations: 1) Sustained Release of existing anti-VEGF antibodies for neovascularization in the eye, and 2) Sustained Release of a novel treatment for glaucoma.

Contact: Brian Pan co-founder & CEO (585-233-5335)

info@biohealthway.com

www.biohealthway.com


BioMolecular Inc.

BioMolecular, Inc.


BioMolecular, Inc. is a leading technology, product and service provider for the life science community. The company has developed a variety of biological research reagents, such as ultra-speed clone vector, ultra-sensitive PCR system, one step Western blot and magic protein sample solution. These reagents are widely used in molecular biological research, drug discovery and clinical diagnosis. The company’s research services include customer gene expression, DNA and RNA purification, gDNA and cDNA library construction, PCR and gene clone, RT-PCR, clinical assay, primer and gene synthesis, DNA sequencing and contracting research project.

Contact:  Gang Wu (917-362-0788) - wug2@yahoo.com

www.bio-mo.com


Bio-Signal Group Corp.

Bio-Signal Group Corp.


Bio-Signal Group was founded by Dr. Andre Fenton to commercialize neuroscience discoveries and sell them to the neuroscience research and clinical markets.  BSG has developed a patent-applied digital signal telemeter (“DT”), which captures and transmits broadband bioelectric signals wirelessly by radio to a receiver device for analysis and storage in a computer.   The DT is an innovative, miniature, battery-operated, portable unit.  The company also sells a proprietary video-based tracking system for behavioral research.  

Contact:  Samah Abdul Baki, CEO, CMO


Bio-Signal Group Corp.

Celmatix


Celmatix is a personalized medicine company focused on women's health. The company leverages predictive analytics and genomics to create products that bring greater clarity to the treatment of infertility and pave the way for proactive fertility management. Powered by its novel research discoveries, Celmatix's products help women make informed decisions about their fertility and provide doctors data-driven tools that complement their patient care.

Contact:  info@celmatix.com

www.celmatix.com


Ceramide Therapeutics, LLC

 

 

CMP Scientific Corp.

CMP Scientific Corp. currently develops, manufactures, and sells nanoLC capillary columns and CE-ESI-MS ion sources. CMP Scientific is founded by experts in the analytical science field, especially the LC-MS and CE-MS coupling technologies. It seeks to become an industry leader as an analytical instrumentation company with five core products/services: nanoLC capillary columns, CE-ESI-MS ion sources, CE instruments, CE consumables, and CE-ESI-MS CRO service.

Contact: James (Qiangwei) Xia, Ph.D., CEO & Principal Scientist (718-360-7803)

 www.cmpscientific.com


Concarlo Holdings, LLC

Concarlo Holdings, LLC (Concarlo) is a start-up drug development company focused on innovative therapeutics and diagnostics jfor unmet needs in oncology.

Contact: LisaMarie Casey - Info@concarlo.com

www.Concarlo.com


CortecNet Corp.

  

CortecNet is a stable isotopes company which identifies, develops, produces and markets innovative products in the fields of NMR, MS, MRI and PET to academia and industry. It is developing new synthesis methods to produce new labeled compounds with stable isotopes for hyperpolarized MRI applications.

Contact: Philippe Corcos, President & CEO - pcorcos@cortecnet.com

http://www.cortecnet.com/


image

DrinkSavvy, Inc.

  

DrinkSavvy, Inc. is developing colorimetric chemical sensors that detect analytes, such as drugs, pathogens, bacteria, and explosives, for real-time detection in field use, without the need for secondary analysis using lab equipment or spectrometry.  The chemical sensors will be embedded in plastic stirrers, straws and cups and provide a colorimetric signal to the consumer in order to prevent consumption of illicit drugs and ensuing drug-facilitated sexual assault and crime.

Contact: Brendan Walker

bwalker@drinksavvy.com

http://drinksavvy.com/


Epibone, Inc.

EpiBone, Inc. is a revolutionary bone reconstruction company that allows patients to grow their own bone. The company's pioneering technology utilizes a scan of the patient's bone defect and the patient's own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.

http://epibone.com/


   

Epi One Inc.

Epi One is a start up biotechnology company that aims to develop tests for the clinical diagnosis of diseases.


Contact: info@epi-one.com (718-676-0696)


FesariusTherapeutics

The need for an alternative to one’s own tissue for wound healing and repair has existed as long as reconstructive surgery itself. FesariusTherapeutics is an early stage company that will develop and manufacture engineered skin and tissue replacement products using patented microsphere hydrogel technology invented by Dr. Jason Spector at the Weill Cornell Medical College Laboratory for Bioregenerative Medicine & Surgery.

Contact: Brett Spector, CEO – brett.spector@fesariustherapeutics.com

http://fesariustherapeutics.com




HemoGenyx LLC

HemoGenyx LLC is a biopharmaceutical company developing new treatments for blood diseases. HemoGenyx’s research and core technology has already made it a leader in making traditional methods of patient conditioning and bone marrow transplants obsolete. The company's technology is an ideal platform for developing the next generation of blood disease treatments. HemoGenyx is committed to continued innovation to bridge the gap between basic research and clinical medicine. 

www.hemogenyx.com


HistoWiz, Inc.

HistoWiz, Inc.

HistoWiz, Inc. is a histopathology service company that processes, embeds, cuts, stains mouse tissue specimens and digitalizes the results for cancer researchers in academia and pharma. Unlike academic core facilities and CROs, HistoWiz guarantees a 3 day turn-around time and provides global access to whole-slide digital results, online collaboration features, low-cost digital data management, a cancer image database, and mouse cancer pathology expertise. The company's mission is to fight cancer cooperatively instead of individually by connecting scientists and doctors for online collaboration.

Contact:  Ke Cheng (212-722-1456)


IAVI

Innovimmune Biotherapeutics, Inc.

Innovimmune Biotherapeutics, Inc. is a specialty drug discovery & exploratory development biotechnology company leading the development of novel first-in-class and best-in-class proprietary oral small molecule NME immunomodulatory drugs for the treatment of Autoimmune and Immunoinflammatory Diseases.

Contact: Anderson Gaweco, M.D, Ph.D.; President & CEO


IAVI

International AIDS Vaccine Initiative (IAVI)

IAVI's AIDS Vaccine Design and Development Laboratory is a versatile facility designed to create novel immunogens, develop viral vectors, evaluate potency and advance promising candidates to clinical evaluation.

The Lab has also established common preclinical standards for the AIDS vaccine field and supports two consortia comprised of scientists from IAVI and academic institutions. Their goals are to understand the basis of naturally evoked, broadly neutralizing antibodies against HIV and to understand the mechanism for the strong protection of live attenuated SIV vaccination in non-human primates to inform the design of AIDS vaccine candidates.  

www.iavi.org



Kinnos Inc.

Kinnos Inc. aims to raise the standard of infectious disease decontamination to protect healthcare workers, patients, and the general public. The company's first product, Highlight, is a point-of-use additive for existing disinfectants that eliminates human error and greatly increases visibility, coverage, and end-user compliance.

Contact: team@kinnos.us

www.kinnos.us


Lucerna, Inc.

Lucerna, Inc. is a RNA-based research tool company that uses a fluorescent aptamer platform for the purpose of: 1.) Developing metabolite sensors for therapeutic diagnostics, 2.) Developing fluorescent assays against hard-to-access targets to enable high-throughput drug discovery, and 3.) Providing plug-and-play RNA imaging systems as research reagents. 

Contact: info@lucernatechnologies.com

 www.lucernatechnologies.com


Mirimus, Inc.

Mirimus is a high-tech business with the expertise in RNAi technologies required for development of superior tools for potent gene silencing, both in cells and animal models. Its advanced RNAi technologies are critical for the generation of animal models that can pave the way drugs are developed by pin-pointing potential toxicities and preventing harmful side-effects of therapeutics in patients. Mirimus is also engaged in the design, development and pioneering of new CRISPR/Cas9 genome editing technologies to develop advanced human disease models that are crucial for the preclinical evaluation of new therapeutics.

Contact: 929-377-3744
www.mirimus.com


New York Huaqi Bioengineering, LLC

New York Huaqi Bioengineering, LLC develops new products in modification or growth of liver organ in vitro to meet the shortage of liver organs in clinic. 

Contact: Lili Xu, Founder & CEO (914-316-0801)

lili_xu@optonline.net or Lili.Xu@downstate.edu


NIRx Medical Technologies, LLC

  

NIRX provides custom technology solutions to the investigative community for a wide range of NIRS imaging applications. While many of our systems are in the field of neuroscience (infants to adults), they are also used for investigation of breast cancer, peripheral vascular disease and the study of small animals.

Contact: Richard Barbour, Vice President (516-759-8750)

rich.barbour@nirx.net - info@nirx.net

http://nirx.net/


Paritic

Paritic, Inc.

Paritic, Inc. provides 3D medical imaging navigation system for minimally invasive surgery. Paritic specializes in medical imaging software and hardware systems for clinical usage. Paritic offers intra-operative navigation system, as well as 3D imaging software products and services for surgical planning, surgical training, virtual surgery post-operative evaluation. With Paritic’s technology, surgery is becoming more secure, more accurate and more effective.

Contact:  Yale Ji (212-901-8608) - yaleji@paritic.com


Parkside Scientific, Inc.

Parkside Scientific Inc. is a privately-held NYC-based preclinical stage drug company that focuses on designing and developing novel drugs for cancers and inflammatory diseases that work through modulation of gene expression. Parkside’s competitive scientific advantages lie in its deep understanding of the biology of signaling proteins, and of the disease mechanisms of cancers and inflammatory disorders triggered by these proteins, and the ability of Parkside structurally to design compounds to prevent the triggering of disease conditions. Parkside is actively developing new drugs for multiple diseases with funding including a grant from the NIH aimed at triple-negative breast cancer, a deadly disease  that has no targeted therapy.

Contact:  Gary K. Duberstein, COO & General Counsel gary.duberstein@pksci.com


PrimaryBio, LLC

PrimaryBio provides superior primary cells to the scientific community at a fraction of the cost of in-house production, freeing up valuable time and resources for the research goals of scientists.  The company developed a proprietary cryopreservation process that delivers the highest post-plating viability profile in the industry, and currently setting the standard for primary neuronal cells. PrimaryBio is applying this technology to numerous cell types to best facilitate the growing use of primary cells in diverse research areas and projects globally.

Contact: Jason Dictenberg, Ph.D., Founder and CEO (718-307-6622) 


ReferWell

  

ReferWell is a cloud-based platform that streamlines the medical referral process. ReferWell allows providers to schedule appointments directly with a specialist physician on behalf of their patient and share clinical data across EMR's and care settings.

Contact: Ilana Bander, CEO (917-903-5489) ilana.bander@urgentconsult.com

https://www.referwell.com/